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Abstract Quercetin is one of the most abundant flavonoids in
the human diet. This study aimed to determine the plasma
concentrations of quercetin in 10 healthy volunteers after the
consumption of a complex meal rich in plant products. Quercetin
was determined in plasma (2 h before, and 3, 7 and 20 h after the
meal), and in a duplicated portion of the meal by HPLC analysis
with an electrochemical detection. The amount of ingested
quercetin was estimated to be 87 mg. Before the meal, quercetin
concentration in hydrolyzed plasmas ranged from 28 to 142 nM.
A marked increase was observed 3 h after the meal in all subjects,
with a mean concentration of 373 nM (S.E.M. = 61). After 7 h,
quercetin concentration in hydrolyzed plasmas decreased and
after 20 h basal levels were found again. The antioxidant
capacities of quercetin, 3P-O-methylquercetin, and of some of
their conjugated derivatives were compared by the measurement
of the conjugated dienes resulting from the Cu2+-induced
oxidation of human LDL. 3P-O-Methylquercetin and conjugated
derivatives of quercetin significantly prolonged the lag phase, but
the magnitude of their effect was about half that of the aglycone.
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1. Introduction
Quercetin is a powerful antioxidant which is regularly con-
sumed by humans. The quercetin content of foodstu¡s is not
yet precisely known but the available data display a range of
2^250 mg quercetin/kg wet weight in fruits, 0^100 mg/kg in
vegetables (onions being especially rich: 200^600 mg/kg), 4^16
mg/l in red wine, 10^25 mg/l in tea, 3^13 mg/l in fruit juices
[1^4]. Quercetin content may vary greatly, depending on the
plant varieties, culture conditions, degree of ripeness, as well
as on food processing (preservation, peeling, mode of cook-
ing) [5]. From the composition tables, the daily consumption
of £avonols plus £avones has been estimated as 3^80 mg,
more than 50% of which is quercetin [6^8]. Two recent epi-
demiological studies support the view that such intake of £a-
vones and £avonols could protect against cardiovascular mor-
tality [6,7]. Quercetin could especially be e¡ective in
preventing atherosclerosis and thrombosis by protecting low
density lipoproteins (LDL) against oxidation, as well as by
lowering the cytotoxicity of oxidized LDL and platelet aggre-
gation. Furthermore, quercetin exhibits antitumor e¡ects in
vitro and inhibits the development of experimental cancers
in animal models [9,10].
Few studies have been carried out on the £avonol bioavail-
ability in humans. In 1975, Gugler [11] was unable to detect
quercetin, conjugated or not, in urine or in plasma from
healthy volunteers after ingestion of 4 g quercetin. During
the last years, analytical methods have been greatly improved,
and concentrations as low as 10 nM can now be determined in
human plasma samples. Hollman et al. [12] have recently re-
ported that the ingestion of 64 mg quercetin (provided as 150
g fried onions) resulted 3 h later in a concentration of 650 nM
quercetin in hydrolyzed plasma. Another study [13] performed
on two healthy volunteers showed that kaempferol was also
absorbed after broccoli intake. Data are still scarce and more
studies are needed on the £avonol bioavailability in humans,
especially to determine food habits that can increase it.
In parallel, the nature of the £avonol metabolites has to be
considered. In vitro studies have established that quercetin is a
potent antioxidant, which could a¡ect the activity of numer-
ous enzymes, or even chelate some metals [14]. But quercetin
can be metabolized into methylated or conjugated derivatives,
as reported in rat [15,16], and no information is available
concerning the potential activity of these metabolites.
The present work was performed (i) to determine the plas-
ma concentration of quercetin metabolites in 10 healthy vol-
unteers after the consumption of a complex meal, and (ii) to
test the ability of some conjugated derivatives of quercetin
and of its 3P-O-methylated form (isorhamnetin) to prevent
in vitro oxidation of human LDL.
2. Materials and methods
2.1. Chemicals
Quercetin, UDP-glucuronic acid, UD-N-acetylglucosamine, UDP-
glucuronyl transferase from rabbit liver and L-glucuronidase/sulfatase
were purchased from Sigma (L’isle d’Abeau, Chesnes, France). Quer-
cetin 3-O-sulfate, kaempferol, luteolin and isorhamnetin (3P-O-meth-
ylquercetin) were from Extrasynthese (Genay, France).
2.2. In vitro glucuronidation
Quercetin and isorhamnetin glucuronides were obtained by in vitro
synthesis. Quercetin or isorhamnetin (100 WM) were incubated 3 h at
37‡C in a HEPES bu¡er (25 mM, pH7.4) in the presence of 10 mM
MgCl2, 4 mM UDP-glucuronic acid, 2 mM UD-N-acetylglucosamine,
and 0.12 U/l UDP-glucuronyl transferase. The conjugation rate was
about 95%.
2.3. Human study
Ten volunteers (four women, six men) participated in the study.
They were between 25 and 54 years of age and their mean body
mass index was 23.1 þ 3.0 kg/m2. All participants were healthy, did
not use any medication and provided informed consent. The protocol
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was approved by the ‘ComiteŁ Consultatif de Protection des Personnes
dans la Recherche BiomeŁdicale’ of Clermont-Ferrand.
The subjects followed a quercetin-free diet for 24 h prior to the
experimental meal. For this purpose, a list of authorized foods and
beverages was given to the participants. At 12.00 h, they were served
an experimental lunch (800 g wet weight), containing foods rich in
quercetin (onions, salad, tomatoes, french beans, apples, berries, red
wine) in combination with quercetin-free foods (chicken, cheese). A
duplicate portion of the meal was stored at 380‡C for the quercetin
composition analysis. An aliquot of wine was collected into vacuum
tubes and stored at 320‡C.
Venous blood samples from the 10 subjects were collected by ven-
ipuncture on heparin, 2 h before, and 3, 7 and 20 h after the exper-
imental meal. Subjects were instructed not to consume any food or
beverage containing quercetin after the experimental meal until the
last blood sampling.
2.4. Treatment of plasma samples
Flavonoids are unstable when the pH of plasma is higher than 7.4;
so, to prevent a drift of the pH due to gradual bicarbonate decom-
position, plasmas were acidi¢ed with 10 mM acetic acid immediately
after blood centrifugation (15 min at 2000Ug), and stored at 380‡C.
A simple treatment procedure was used, to limit the £avonoid
losses; namely, plasmas were acidi¢ed (to pH 4.9) with 0.1 volume
of 0.58 M acetic acid solution and treated for 30 min at 37‡C in the
presence or in the absence of 5U106 U/l L-glucuronidase and 2.5U105
U/l sulfatase. Flavonoids were extracted with 2.75 volumes of acetone.
After centrifugation, 20 Wl of the supernatant was directly injected in
the column for HPLC analysis. The percentage of recovery has been
estimated to be over 85% using pure quercetin or isorhamnetin in
plasma. Analysis were performed in duplicate.
2.5. Treatment of food samples
The duplicate portion of food was lyophilized (15‡C, 1032 mbar,
72 h) to obtain a homogeneous powder. This sample and the wine
sample were extracted and hydrolyzed with 200 volumes of 1.2 M HCl
solution in 50% aqueous methanol (v/v). Extracts were re£uxed at
90‡C for 2 h, puri¢ed on glass ¢lters and subsequently made up to
400 volumes with 50% aqueous methanol.
2.6. Quercetin determination
Quercetin was determined in plasma, wine and food extracts by
HPLC analysis coupled with a coulometric detection. The column
(150U4.6 mm Inertsil, Interchim, France) was eluted isocratically (1
ml/min) at 30‡C with a 30 mM NaH2PO4 bu¡er containing 45%
methanol (pH 2.6). Electrochemical detection was performed with a
Coulochem II (Eurosep, France), the potential was set at +150 mV.
The limits of detection for quercetin and isorhamnetin were 5 nM and
10 nM respectively.
2.7. Human LDL preparation
A pool of plasmas collected from the 10 subjects before the test
meal was used. The plasma LDL fraction was prepared by sequential
density ultracentrifugation, in the presence of 1 g/l EDTA. Plasma
was adjusted to a density of 1.019 kg/l with solid KBr in sealed tubes
(OptiSeal tubes, Beckman, Palo Alto, CA) and centrifuged 2 h at
645 000Ug, 15‡C (L90, rotor NVT 90, Beckman). The top fraction
(chylomicron+VLDL) was removed and the remaining plasma was
adjusted to 1.063 kg/l with solid KBr and centrifuged 2 h at
645 000Ug, 15‡C. The top fraction (LDL) was collected and dialyzed
24 h (at 4‡C in darkness) against phosphate bu¡er (0.1 M H3PO4/0.16
M NaCl, pH 7.4).
2.8. Measurement of the oxidative susceptibility of lipoproteins
The ¢nal protein concentration (BCA protein reagent kit, Pierce,
Interchim, France) in human LDL fractions was adjusted to 50 mg/l.
The LDL fraction was supplemented with ethanol (control condi-
tions), quercetin, isorhamnetin, quercetin 3-O-sulfate, which was the
sole sulfo-conjugated form of quercetin commercially available, a mix
of four quercetin glucuronides or a mix of four isorhamnetin glucuro-
nides obtained by in vitro conjugation of quercetin or isorhamnetin by
UDP-glucuronyl transferase. Oxidation was initiated by addition of a
freshly prepared CuSO4 solution (10 WM ¢nal concentration) at 37‡C.
The kinetics of the oxidation of lipoproteins were determined by
monitoring continuously the changes in the conjugated diene absorb-
ance (234 nm) at 37‡C on an Uvikon 930 spectrophotometer (Kon-
tron, France). Lag time values are means þ S.E.M. (n = 5).
3. Results
By the HPLC-ECD analysis of the experimental meal and
of the red wine samples, the quantity of ingested quercetin has
been estimated as 87 mg, 4.5% of which was provided by the
red wine. No kaempferol, luteolin or isorhamnetin could be
detected in the meal.
Before the experimental meal, quercetin concentration in
plasmas treated with L-glucuronidase/sulfatase ranged from
28 to 142 nM in the 10 volunteers (Fig. 1). A marked increase
was observed 3 h after the meal in all the subjects. Quite
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Fig. 1. Quercetin concentration in plasmas treated with L-glucuronidase/sulfatase, from 10 healthy volunteers before and after a meal rich in
plant products.
C. Manach et al./FEBS Letters 426 (1998) 331^336332
homogeneous values were obtained for eight subjects, with a
mean concentration of 344 nM (S.E.M. = 29), but a particu-
larly high (843 nM) and a low (129 nM) concentration were
observed in subjects 6 and 9 respectively. After 7 h, the quer-
cetin concentrations in hydrolyzed plasmas were similar (for
three subjects) or lower than those observed 3 h after the
experimental meal, but were still higher than the basal con-
centrations. 20 h after the test meal, basal concentrations were
FEBS 20134 27-4-98
Fig. 2. Representative chromatogram of human hydrolyzed plasma before (A) and 3 h after (B) the experimental meal. Q = quercetin.
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found again. It can be noted that the subjects 6, 7 and 8 who
had the highest quercetin concentrations in hydrolyzed plas-
mas before the experimental meal also had the highest con-
centrations 20 h after the meal. Yet, they were not necessarily
those who showed the greatest increase 3 h after the meal. No
signi¢cant di¡erences could be observed between women (sub-
jects 1^4) and men (subjects 5^10).
Fig. 2 shows typical chromatograms of plasmas, hydrolyzed
by L-glucuronidase/sulfatase, from the same subject, 2 h be-
fore and 3 h after the experimental meal. The low voltage
used (150 mV) was very selective and only a few compounds
can be oxidized at such voltage. The increase in the quercetin
peak height (retention time 16.1 min) is very clear. Two
other peaks, with retention times of 13.2 and 18.4 min,
appeared, but were not identi¢ed. However, these compounds
could not correspond to glycosides, which exhibit lower
retention times (6 4 min) in such chromatographic condi-
tions. Signi¢cant concentrations of isorhamnetin (100^200
nM 3 h after the meal, with a 30% decrease at 7 h, and a
total loss after 20 h; retention time 34.5 min) were found in
plasma samples from three of the 10 subjects. In the other
subjects, no isorhamnetin could be detected (limit of detection
10 nM).
Plasma samples obtained 3 h after the experimental meal
were also analyzed by HPLC coupled to UV detection (Hy-
persil BDS column from Interchim, 27% acetonitrile+73%
water/H3PO4 (99.5/0.5), 1.5 ml/min, 370 nm). Both methods
gave the same quercetin concentration within a 7% variation,
but the limit of detection was higher with UV than with cou-
lometric detection (150 vs. 5 nM).
We previously reported that, in rats fed a quercetin-supple-
mented diet, plasma quercetin was completely conjugated with
glucuronic acid or sulfate. Similarly, no trace amounts of free
quercetin could be detected in human plasma before L-glucu-
ronidase/sulfatase hydrolysis, which implies that all circulating
metabolites of quercetin are conjugated derivatives. Thus it
was important to test the antioxidant activity of some conju-
gated forms of quercetin, obtained as described in Section 2.
Fig. 3A shows that quercetin increased, in a concentration-
dependent manner, the lag phase of conjugated diene forma-
tion: +110 þ 5 min at 0.25 WM and +310 þ 18 min at 0.5 WM.
When present at 0.5 WM, quercetin glucuronides or quercetin
3-O-sulfate also signi¢cantly delayed copper-induced lipopro-
tein oxidation (+90 þ 8 min and +110 þ 10 min respectively) ;
however, the magnitude of their e¡ects was lower than that of
the aglycone. The simultaneous presence of 0.5 WM quercetin
glucuronides and 0.5 WM quercetin 3-O-sulfate resulted in an
inhibition of conjugated diene appearance quite similar to that
observed with 0.5 WM quercetin. Isorhamnetin, which was
recovered in some plasmas, also delayed the oxidation of hu-
man LDL (+90 þ 5 min), but was less potent than quercetin
(Fig. 3B). As for quercetin, the e¡ect of isorhamnetin glucuro-
nides was lower than that of the aglycone. It could be noted
that, even if all the compounds signi¢cantly prolonged the lag
phase, they had no detectable e¡ect on the rate of lipid oxi-
dation during the propagation phase.
4. Discussion
This present study shows that metabolites of the dietary
antioxidant quercetin are found in the blood circulation after
consumption of various vegetables and fruits.
The quercetin content of the experimental meal was 87 mg,
which can be compared to the 89 mg obtained by Hollman et
al. [17] with 150 g fried onions. While this represents about
three-fold the mean daily intake estimated in the Northern
Europe, it seems quite easy to reach this level of quercetin
intake with a Mediterranean diet rich in fresh plant products.
This clearly illustrates the great di¡erences of intake that can
occur between individuals, depending on their food habits.
The general features of quercetin absorption in rats have
been previously described [16,18]. Brie£y, the absorbed quer-
cetin is transported bound to albumin, chie£y methylated in
the 3P position, and entirely conjugated with glucuronic acid
and sulfate. Recent studies have speci¢ed that the conjugated
forms are mostly glucurono-sulfated derivatives [19]. In spite
of the low limit of detection (5 nM) of our HPLC-ECD meth-
od, we failed, as in rat plasmas, to detect trace amounts of
free quercetin in non-hydrolyzed human plasma samples.
Thus plasma quercetin metabolites are also conjugated deriv-
atives in humans. In parallel, it seems that the methylation
process is less important in humans than in rats. Although
there are probably di¡erences between species, it must be
noted that in plasmas from rats fed a 2 g/kg quercetin diet,
the isorhamnetin concentration was about four times higher
than that of quercetin, whereas in rats fed a lower amount of
quercetin (6 0.5 g/kg), the isorhamnetin/quercetin ratio was
markedly lower (about 2) (data not shown). This suggests that
the methylation process could be important only when rela-
tively high quantities of quercetin are ingested, which could
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Fig. 3. Inhibition of the Cu2-induced oxidation of human LDL
(measured by conjugated diene formation) by (A) quercetin or its
conjugated derivatives (Q = quercetin; QS = quercetin-3-O-sulfate;
QG = quercetin glucuronides) or (B) isorhamnetin or its conjugated
derivatives (Iso = isorhamnetin; IsoG = isorhamnetin glucuronides).
Values are from a representative experiment.
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explain why only low amounts of isorhamnetin were found in
human plasma.
The quercetin concentrations (about 350 nM) obtained in
hydrolyzed plasmas 3 h after the experimental meal were
about twice as low as those reported by Hollman et al. [12]
after ingestion of onions, but were in the same range as those
obtained by the same authors after ingestion of applesauce
[20]. It cannot be ruled out that the blood sampling performed
3 h after the meal in our experiment could not exactly corre-
spond to the maximal absorption peak, so that we could
slightly underestimate the quercetin concentrations. Neverthe-
less, the di¡erences between experiments may also result from
the nature of the quercetin glycosides present in food, or from
the in£uence of the other constituents of foods. Indeed, the
presence of elements liable to bind quercetin (dietary ¢bers,
proteins, etc.), or to solubilize it (alcohol) could modify the
kinetics or the extent of its absorption.
With regard to the absorption of glycosides, which are the
main forms present in foods, we previously reported that rutin
was absorbed more slowly than quercetin in rats since it had
¢rst to be hydrolyzed by bacterial glycosidases in the cecum
[21]. According to Hollman’s work on ileostomy subjects [17],
marked di¡erences also exist in humans between absorption
of quercetin and of its glycosides: glucosides from onions
were better absorbed than quercetin, which was itself better
absorbed than rutin. The authors made the assumption that
glucosides could be absorbed as such, by a mechanism that
would implicate the glucose carrier. However, the presence of
quercetin glycosides in plasma is still speculative. The plasma
treatment with L-glucuronidase/sulfatase used in the present
study and the acid treatment employed by Hollman both hy-
drolyze glycosides together with glucuronides, so that it is
impossible to detect their presence in a native form. Yet, Pa-
ganga and Rice-Evans [22], using an array diode detection
method, found high concentrations of quercetin glycosides
(0.5^1.6 WM) in plasma samples from non-supplemented sub-
jects. This result is quite surprising and has not been con-
¢rmed to our knowledge. Conjugated derivatives could have
been mistaken for glycosides, as they exhibit very similar re-
tention times and spectral pro¢les, as we have checked in our
laboratory.
The rapid post-prandial absorption of quercetin indicates
that it probably takes place in the proximal part of the intes-
tine. Several hypotheses can be considered: the ¢rst one is
closely akin to that of Hollman, involving an absorption of
the glycoside forms. In this case, the possibility of a rapid
conjugation of the glycosides should be examined. The second
hypothesis is that quercetin is present in the proximal part of
the intestine, resulting from hydrolysis of glycosides during
food processing (by release of vegetal glycosidases), or during
the ¢rst phase of the digestion in the stomach. Moreover, free
quercetin could also be present in signi¢cant amounts in
foods, as has been reported for some onion species [1].
Various £avonoids inhibit the peroxidation of human LDL
induced in vitro by cupric ions or macrophages [23,24]. Quer-
cetin is one of the most potent antioxidant polyphenols, ac-
cording to (i) the unsaturation of its heterocycle, conjugated
with the 4-oxo function, (ii) the presence of the o-diphenolic
part of the B cycle, and (iii) the hydroxyl groups in positions 3
and 5 [25]. The mechanisms involved in preventing LDL ox-
idation or delaying K-tocopherol consumption are not yet
fully established (inhibition of free radical formation, free
radical scavenging, K-tocopherol regeneration), but quercetin
could act at the lipid/water interface, since it is not tightly
bound to lipoproteins, in contrast to lipophilic antioxidants
[26]. The glucuronidation or the sulfation of quercetin modi-
¢es its hydrophobicity and the possibilities of electron deloc-
alization so it could be predicted that the antioxidant e¡ect of
quercetin conjugates could be di¡erent from that of the agly-
cone. In the present work we demonstrate that some conju-
gated derivatives of quercetin also signi¢cantly delay the
Cu2-induced oxidation of human LDL. Even if the magni-
tude of this inhibition was about half that measured with the
aglycone, conjugated derivatives of quercetin could exert
physiological e¡ects, possibly in synergism with other com-
pounds from fruits and vegetables.
In conclusion, the present work shows a marked increase in
the plasma concentration of conjugated derivatives of querce-
tin after consumption of a meal rich in plant products. Quer-
cetin is entirely present as conjugated derivatives, which could
modify its biological e¡ects. After 20 h without new quercetin
ingestion, plasma concentrations return to quite low basal
levels. This implies that bene¢cial e¡ects of £avonols should
depend on a regular consumption of plant foods rich in these
polyphenols. Additional studies must be performed to under-
stand the mechanisms of intestinal absorption of £avonols
and to determine the exact nature of their metabolites before
assessing their actual role on human health.
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